subscribe: Posts | Comments

Menopausal hormone therapies may increase breast cancer risk

0 comments

Summary of story from The Times of India, November 19, 2011

A study at UCLA’s Jonsson Comprehensive Cancer Center has found that women taking menopausal hormone therapy that is a combination of both estrogen and progestin may be at a higher risk of developing breast cancer.

The researchers discovered that women who take the combination therapy and experience new-onset breast tenderness had a 33 per cent greater subsequent risk of developing breast cancer than women who do not experience breast tenderness.

In contrast women who took hormone therapy consisting only of estrogen did not have a higher risk of breast cancer following breast tenderness.

Menopausal hormone therapy is used to relieve symptoms in post-menopausal women.

Leave a Reply

Your email address will not be published. Required fields are marked *